OAOriginals publishes a diverse range of scholarly contributions, including original research articles, review articles, clinical trials, guidelines, opinions, short communications, images, case reports, and letters to the editor. Our mission is to establish OAOriginals as a truly international publisher, both in its perspective and the global diversity of its authors.
By publishing high-quality research, OAOriginals contributes to the worldwide enhancement of medical standards. The publisher welcomes submissions related to medical science and medical care, including clinical and basic medical science, as well as public health. In addition, OAOriginals encourages the exploration of non-clinical studies, such as health policy and expert opinions.
All unsolicited submissions undergo comprehensive peer review by recognized subject experts, ensuring rigorous scholarly integrity. OAOriginals is published quarterly (January, April, July, and October), maintaining a reliable and consistent platform for groundbreaking research.
Manuscripts must be prepared in accordance with the "Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals" set forth by the International Committee of Medical Journal Editors (ICMJE).
OAOriginals is committed to open-access publishing with no submission fees, ensuring that research remains accessible to all.
Join us in shaping the future of medical science through unrestricted knowledge exchange!
At OAOriginals, we accept a diverse range of scholarly contributions. Once you determine the correct article type for your submission, please review our Manuscript Preparation Guidelines carefully before submitting your work.
Detailed reports on original research, presenting compelling new findings with significant impact on medical practitioners and researchers.
Comprehensive overviews and updates on specific topics in medical science. These articles summarize existing research, highlight advancements, and provide insights into future directions.
Studies detailing randomized investigations into the safety, efficacy, and optimal dosage schedules of diagnostic, therapeutic, or prophylactic techniques, devices, or drugs.
Recommendations designed to optimize patient care, based on systematic reviews of evidence and assessments of the benefits and risks of various treatment approaches.
Evidence-based perspectives on critical issues in public health, health policy, or clinical medicine, written in a scholarly manner and supported by well-referenced research.
Concise and rapid reports (under 1,200 words) presenting new and significant findings, including confirmatory studies—even those with negative results—of previously published research.
Original, high-quality medical images showcasing extraordinary findings with practical relevance for medical professionals.
Detailed accounts of rare or exceptionally unique clinical cases with high educational value for diagnosis and treatment. OAOriginals publishes case reports only when they present the world's first reported occurrence or an exceptionally rare condition.
Brief, constructive commentaries responding to recently published articles in the journal, fostering scholarly discussion and engagement.
OAOriginals is committed to publishing high-quality, impactful research that advances the field of medical science. We encourage authors to carefully select the appropriate article type and adhere to our submission guidelines to ensure a smooth publication process.
The manuscript preparation guidelines for OAOriginals are based, in part, on the "Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals" published by the International Committee of Medical Journal Editors (ICMJE). Authors should refer to the ICMJE Recommendations for any formatting or reporting details not specifically mentioned in this guideline.
Authors wishing to include figures, tables, or text passages that have been previously published must obtain permission from the copyright owner(s) for publication in both print and online formats. Proof of permission must be provided when submitting the manuscript.
For manuscripts written by non-native English speakers, editing by a native English speaker—preferably with expertise in medical editing—is strongly recommended prior to submission. This ensures clarity, accuracy, and adherence to international academic standards.
All manuscripts must adhere to the formatting and submission guidelines outlined by OAOriginals. Submissions that do not fully comply with these requirements will be returned to the corresponding author for technical revision before undergoing peer review.
OAOriginals is committed to maintaining high editorial standards to ensure the integrity and impact of published research. We appreciate authors' attention to these guidelines to facilitate a smooth submission and review process.
All manuscripts must be written in English and formatted according to the specified guidelines. The text should be double-spaced throughout. Each page must include both line numbers and page numbers to facilitate reviewer feedback.
The manuscript should be structured in the following sequence:
The title page should be prepared separately from the main manuscript and must include the following details:
Each manuscript must include an abstract of no more than 300 words, structured according to the article type:
Regardless of the article type, the abstract must include 3-8 keywords. For clinical trials, the abstract must also contain the registration number and the name of the registration database.
For each article type, authors must follow the specified structure and format as outlined below:
| Article Type | Structure | Word Limit | Tables | Figures | References |
|---|---|---|---|---|---|
| Original Research Article | Introduction, Materials and Methods, Results, Discussion | Up to 5,000 words | 5 max | 6 max | No limit |
| Review Article | Narrative: No headings required Systematic: Introduction, Materials and Methods, Results, Discussion |
4,000 max | 10 max | 10 max | 75 max |
| Clinical Trial | Introduction, Methods, Results, Discussion | Up to 3,500 words | 5 max | 6 max | No limit |
| Guideline | Unstructured | Up to 4,000 words | 7 max | 10 max | No limit |
| Opinion | Unstructured | Up to 1,500 words | 2 max | 3 max | 5 max |
| Short Communication | Concise format | Up to 1,200 words | 2 max | 3 max | 15 max |
| Images | Brief description | Up to 150 words | N/A | 4 max | 5 max |
| Case Report | Introduction, Case Report, Discussion | Up to 750 words | 3 max | 4 max | 10 max |
| Letter to the Editor | Brief commentary | Up to 400 words | 1 combined | 1 combined | 5 max |
Authors are responsible for ensuring the accuracy of all cited references. The References section should be placed directly after the conclusion of the main text.
Journal article
1. Guiot BH, Khoo LT, Fessler RG. A minimally invasive technique for decompression of the lumber spine. Spine. 2002;27(4):432-8.
Journal article in a language other than English
2. Paroussis D, Papaoutsopoulou C. [Porcelain laminate veneers (HI-ERAM)]. Odontostomatol Proodos. 1990;44(6):423-6. Greek.
Online journals
3. Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 1 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htmArticle
Entire book
4. Jenkins PF. Making sense of the chest x-ray: a hands-on guide. New York: Oxford University Press; 2005. 194 p.
Book chapter
5. Riffenburgh RH. Statistics in medicine. 2nd ed. Amsterdam (Netherlands): Elsevier Academic Press; 2006. Chapter 24, Regression and correlation methods; p. 447-86.
For reference styles related to other media formats or additional details, consult Citing Medicine, published by the National Library of Medicine (US).
Additionally, AI-generated material must not be cited as a primary source in references.
All measurements for length, height, weight, and volume should be expressed in metric units (e.g., meters, kilograms, or liters) or their decimal multiples. Temperature must be reported in degrees Celsius, and blood pressure should be stated in millimetres of mercury. All measurements must comply with the International System of Units (SI).
Use a capital "L" when indicating liter in text, figures, and tables (e.g., g/dL, mg/dL, IU/L, and mEq/L).
Abbreviations should not be included in the title. Define each abbreviation upon first use in the text, figures, and tables, then maintain consistent usage throughout the document.
Brand names of drugs, devices, and other products should not be used unless absolutely necessary for the discussion. Instead, use a descriptive name whenever possible.
In alignment with the International Committee of Medical Journal Editors (ICMJE) policy, all clinical trials must be registered in a public trial registry before enrolling the first participant. Clinical trials are defined as research projects that prospectively assign individuals or groups to an intervention—whether or not a comparison or control group is included—to investigate cause-and-effect relationships between health-related interventions and outcomes. These interventions may include, but are not limited to, pharmaceutical treatments, surgical procedures, medical devices, behavioral therapies, educational programs, dietary modifications, quality improvement initiatives, and changes in care processes.
The OAORIGINALS mandates that clinical trials be registered in publicly accessible databases that are free of charge, open to all prospective registrants, managed by non-profit organizations, equipped with verification mechanisms to ensure data accuracy, and searchable electronically.
Manuscripts submitted to the journal must include the unique registration number within the abstract as proof of registration. Additionally, the name of the registration database must be specified. For details regarding the minimum registration data set, refer to the ICMJE recommendations: ICMJE Clinical Trial Registration.
Accepted registries include, but are not limited to, the following:
Furthermore, authors reporting randomized clinical trials must adhere to the published CONSORT guidelines (CONSORT Statement). The recommended checklist must be completed and submitted with the manuscript. A trial flow diagram should also be included as a figure.
Different study designs have established reporting guidelines that authors are encouraged to follow. These guidelines help ensure clarity, transparency, and consistency in research reporting. Here are some widely recognized standards:
To find the most appropriate guideline for your study, visit the EQUATOR Network at https://www.equator-network.org/. Following these standards will enhance the quality and impact of your research.
When completing a Reporting Guideline checklist, it is essential to revise your manuscript to ensure it fully addresses the relevant reporting criteria outlined in the checklist. Reporting guidelines are designed not only to help improve the transparency and quality of your research but also to serve as a framework for structuring your manuscript effectively. The checklist should not simply be completed as a formality—it should be actively integrated into the writing process to enhance clarity and completeness. Dedicating time to aligning your manuscript with these reporting standards can significantly strengthen its quality and potentially increase its chances of publication.
The OAORIGINALS encourages authors of manuscripts involving clinical trials to share their de-identified research data. This includes, but is not limited to, raw and processed data, software, algorithms, protocols, methods, materials, study protocol, statistical analysis plans, informed consent forms, clinical study reports, and analytic code.
In compliance with ICMJE requirements, all manuscripts reporting clinical trial results must include a data-sharing statement with a link to the trial registration. The statement should specify:
This statement is published alongside the manuscript to ensure transparency and facilitate further research.
Manuscripts must be submitted electronically through the online system: OAO Submission Portal.
When uploading files, authors should follow this order:
The total file size must not exceed 100 MB. Upon submission, manuscripts undergo automatic plagiarism screening. If the plagiarism rate is 30% or higher, the manuscript may be returned to the corresponding author for revision.
The OAO employs iThenticate to assess text overlap and originality. Authors can find additional information and pre-screening options at iThenticate.
All authors listed in the manuscript will receive an email notification upon submission.
Peer review plays a crucial role in evaluating manuscripts submitted to the OAORIGINALS. Every article sent for full peer review undergoes a comprehensive, fair, and unbiased assessment.
Initially, the editors review all submitted manuscripts to determine their eligibility for publication. This evaluation considers:
Manuscripts that meet these criteria are typically sent to two field experts for further review. The OAORIGINALS follows a single-anonymized peer review process, meaning that reviewers remain anonymous while authors' identities are known to them.
The editors carefully assess peer review feedback and decide whether to:
The OAORIGINALS adheres to the Committee on Publication Ethics' Ethical Guidelines for Peer Reviewers. Reviewers must:
Reviewer guidelines can be found on the publisher's homepage.
Once the review is complete, the decision letter—including editorial and peer reviewer comments—will be sent to the corresponding author via email.
Manuscripts requiring revision must be thoroughly updated in accordance with the comments provided by both the reviewers and editors. Authors are required to submit a detailed point-by-point response letter, addressing all feedback received.
The revised manuscript should be submitted within 12 weeks from the date of the prior decision. Before submission, all authors must approve the revisions to ensure accuracy and consensus.
Manuscripts submitted by editors, Editorial Staff members, or journal personnel undergo the same review process as all other submissions. However, these individuals are excluded from any editorial decisions regarding their own manuscript. They do not have access to their submission or any details about the review process beyond what is communicated in the editor's decision letter.
The ScholarOne submission and peer review system is designed to anonymize any individual in an editor or reviewer role from manuscripts they have authored.
Additionally, manuscripts submitted by editors, Editorial Staff, or journal personnel must include a conflict-of-interest statement, disclosing their personal affiliation with the OAO.
The OAORIGINALS upholds the highest standards in academic publishing and adheres to established guidelines and best practices. The OAO follows:
By adhering to these standards, the OAORIGINALS ensures integrity, transparency, and excellence in scholarly publishing.
All authors listed in the manuscript must meet the following four criteria, as defined by the International Committee of Medical Journal Editors (ICMJE) in their recommendations for scholarly publication:
Individuals who do not meet all four criteria should not be listed as authors. Guest or honorary authorship is strictly prohibited.
In line with the Committee on Publication Ethics (COPE) and the World Association of Medical Editors (WAME), OAO does not recognize Artificial Intelligence (AI) tools—such as ChatGPT or Large Language Models (LLMs)—as authors, as they cannot fulfil the ICMJE authorship requirements.
The corresponding author must ensure that all listed authors read and approve the manuscript before submission. Those who do not meet the authorship criteria may be acknowledged individually or collectively under an "Acknowledgements" section on the title page. Examples of contributions that do not qualify for authorship include funding acquisition, general supervision of a research group, administrative support, writing assistance, technical editing, language editing, and proofreading.
Upon submission, an email will be sent to all authors requesting confirmation of authorship, and each author must respond as per the instructions provided.
Authors must resolve and finalize any disputes regarding the order of authorship before submission. The final author list must be established by the end of the manuscript's revision phase during peer review. Any authorship modifications—including additions, deletions, or reordering—must be discussed and approved by all authors. Requests for such changes must be documented in a Change of Authorship Request Form, signed by all authors.
After manuscript acceptance, further modifications to author names or order are not permitted.
Based on the guidelines set forth by COPE, WAME, and ICMJE, the OAORIGINALS does not permit artificial intelligence (AI)-assisted tools or technologies—such as Large Language Models (LLMs), chatbots, or image generators—to be credited as authors or co-authors. Since these AI tools cannot take responsibility for the accuracy, integrity, or originality of a work, they do not fulfil the authorship criteria outlined by ICMJE.
Human authors remain fully accountable for all submitted materials, including any utilization of AI-assisted technologies. AI tools must not be cited as authors, and human authors bear responsibility for preventing plagiarism, whether in textual content or AI-generated imagery. Furthermore, authors must disclose any use of AI-assisted tools upon submission and within the Materials and Methods section (or equivalent). This includes AI's involvement in manuscript writing, image or graphic creation, as well as data collection and analysis.
The OAORIGINALS welcomes manuscript submissions that have been previously posted on non-profit preprint servers like bioRxiv and medRxiv. Authors submitting such manuscripts must inform the editor and provide details regarding the preprint posting, including the digital object identifier (DOI) of the preprint version.
Manuscripts that have already been published or are under consideration for publication in another journal, regardless of language, will not be accepted. By submitting a manuscript, authors confirm that the work has not been previously published, is not being reviewed elsewhere, and has received approval from all co-authors for submission. The final decision regarding the acceptance of peer-reviewed manuscripts rests with the editors. However, manuscripts posted on non-profit preprint servers are exempt from this restriction.
All details related to the manuscript, including author information, reviewer identities, editorial comments, and the contents of the decision letter, are treated as confidential and will not be shared with any third parties.
The OAORIGINALS does not consider the prior archiving of manuscripts on non-profit preprint servers before submission as redundant or duplicate publication.
However, manuscripts under consideration for publication in another journal—including advanced publications such as "in-press" or "E-pub ahead of print" articles in any language—may be classified as redundant or duplicate publication.
Authors must formally inform the editor of all submissions and any previous reports that could be deemed redundant or duplicate publications of the same or similar work. Such materials must be properly referenced in the new submission, and copies of the related work should be included. Abstracts or posters presented at scientific conferences do not qualify as prior publications.
If a manuscript is found to be a redundant or duplicate publication without proper disclosure, editorial actions may follow. These actions can include immediate rejection, retraction of published work, issuance of a public notice of violation, and revocation of publishing privileges.
Authors seeking guidance on acceptable secondary publication should refer to the ICMJE Recommendations.
According to the ICMJE Recommendations, a conflict of interest (COI) arises when professional judgment regarding a primary interest, such as patient welfare or research validity, may be influenced by secondary interests, such as financial gain.
All authors must disclose any financial relationships, activities, affiliations, or associations that exist or have existed within the 36 months prior to submission with commercial organizations, institutions, or other entities with an interest in the manuscript's subject matter, materials, or processes. These disclosures include, but are not limited to:
Authors must disclose any potential COI relevant to the study on the title page under the heading "Conflicts of Interest", using examples such as:
"A (author name) received honoraria from Z (entity name); B holds an advisory role in Y; C is an employee of Company X."
If no conflicts exist, authors should state: "The authors declare that there are no conflicts of interest." The provided disclosures will be published as submitted if the manuscript is accepted.
Following submission, all authors will receive an email notification to confirm and complete their COI disclosure forms (e-forms).
Any funding received from government or non-profit organizations relevant to the study must be acknowledged on the title page under "Sources of Funding." Authors must use one of the following formats:
Authors must ensure full and accurate details of funding sources and grant numbers are included.
Clinical research involving human subjects or materials of human origin must adhere to the principles set forth in the Declaration of Helsinki. Additionally, the Materials and Methods section must include a statement confirming that the research received approval from the Institutional Review Board (IRB) of the authors' affiliated institutions. This statement should include the IRB approval code and the name of the institution granting the approval. Researchers without access to an ethics review committee should ensure their work aligns with the ethical standards outlined in the Declaration of Helsinki.
Articles presenting data from animal testing must confirm, within the Materials and Methods section, that the testing design has received approval from the affiliated institution's Animal Care and Use Committee.
For studies reporting new DNA sequences, authors must submit the data to GenBank and provide the corresponding accession number in the article.
For research involving human subjects, the manuscript must explicitly state that written consent has been obtained from all patients (or their parent or legal guardian) for publication, including any photographs.
Personal identifiers such as patient names, initials, hospital identification codes (patient IDs), specific dates, or any other information that could reveal patient identities must not appear anywhere in the manuscript—including Figures and Tables—unless the information is essential for scientific purposes and patient consent has been obtained. Any images should be limited to the affected areas only.
The Editorial Staff of the OAORIGINALS adheres to the COPE International Standards for responsible research publication, ensuring ethical practices among authors, reviewers, and editors when addressing allegations of misconduct. For further details, please refer to our Ethical Policies.
All manuscripts submitted to the OAORIGINALS must be original works by the authors and must not duplicate previously published content in any language. Authors must guarantee that their manuscript is not simultaneously submitted to or under consideration by another journal.
Authors bear full responsibility for the originality and accuracy of their submitted manuscripts. All records and data presented must be free from fabrication, manipulation, or falsification.
Authors confirm that a single research study or dataset has not been deliberately divided into multiple parts to increase the number of submissions or publications across the OAO Journals or other journals over time ("salami publication").
All external sources, including data, text, ideas, or theories, must be appropriately credited and cited in accordance with the References section of the Manuscript Preparation guidelines.
Any identified misconduct is subject to investigation by the Editorial Staff following COPE recommendations. If concerns arise during the inquiry, the author will be contacted to address the issue. In cases of suspicion after publication, the Editors-in-Chief may issue an Expression of Concern.
If publication ethics are violated—regardless of severity—actions may include manuscript retraction, formal notice of misconduct, notification to the author's institution, and an embargo on future submissions to the OAORIGINALS.
Once a manuscript is accepted for publication, galley proofs will be provided to authors for minor corrections, such as spelling errors and omitted characters or letters. Any additional revisions after acceptance are not permitted unless requested by the Editorial Staff of the OAO. Authors must complete the proofing process as directed by the Support Office and promptly submit the revised proof via email.
The Editorial Staff reserves the right to revise terminology, phrasing, and other elements of the manuscript without author consent. Sections requiring corrections will be annotated with comments indicating necessary revisions.
Following publication, any further changes or corrections can only be made through an Erratum, which will be hyperlinked to the original article.
Copyright for articles and their content published in the OAORIGINALS is held by OAORIGINALS. However, all works in the OAO are licensed under the Creative Commons Attribution License. This license allows anyone to download, reuse, copy, reprint, distribute, or modify published articles, provided the original authors and source are properly cited. No prior permission from the publisher is required. The license details can be found on the last page of the published PDF of each article.
To prevent potential conflicts of interest in editorial decision-making, the OAORIGINALS does not accept advertising from pharmaceutical companies, device manufacturers, or other commercial entities. This policy ensures that advertisements from companies with competing interests do not appear alongside published articles.
OAO is an open access, not-for-profit publisher without any source of funding and is running for the betterment of the scientific society with a cause to deliver the updates in the scientific society to nook and corner of the world.
The cost covers entire peer review tools and systems, journal development, copy editing, language editing, administration process, online hosting and permanent archiving of article.
Article processing charges will be paid by the authors before publishing their articles in the journal. For any queries regarding article processing charges and invoice details, please email us to info@oaoriginals.com.
Authors have the opportunity to order reprints of their articles with reduced color costs when they receive their article proofs for approval prior to publication.
The Publisher is associated with various news outlets. All the published articles will be promoted and marketed through the press releases from affiliated news outlets for enhanced readership and citations. Besides publishing the press releases, these news outlets also involved in article promotion through newsletters. They send out emails to the readers who are particularly involved in the similar research to the published article.
